These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
455 related items for PubMed ID: 31539132
1. LINC01096 knockdown inhibits progression of triple-negative breast cancer by increasing miR-3130-3p. Wang GP, Mou ZL, Xu YY, Liu GX, Wang DM, Zhang HP. Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7445-7456. PubMed ID: 31539132 [Abstract] [Full Text] [Related]
3. LncRNA LINC00173 enhances triple-negative breast cancer progression by suppressing miR-490-3p expression. Fan H, Yuan J, Li X, Ma Y, Wang X, Xu B, Li X. Biomed Pharmacother; 2020 May; 125():109987. PubMed ID: 32058222 [Abstract] [Full Text] [Related]
4. Long noncoding RNA Linc00339 promotes triple-negative breast cancer progression through miR-377-3p/HOXC6 signaling pathway. Wang X, Chen T, Zhang Y, Zhang N, Li C, Li Y, Liu Y, Zhang H, Zhao W, Chen B, Wang L, Yang Q. J Cell Physiol; 2019 Aug; 234(8):13303-13317. PubMed ID: 30618083 [Abstract] [Full Text] [Related]
5. MiR-25-3p promotes the proliferation of triple negative breast cancer by targeting BTG2. Chen H, Pan H, Qian Y, Zhou W, Liu X. Mol Cancer; 2018 Jan 08; 17(1):4. PubMed ID: 29310680 [Abstract] [Full Text] [Related]
6. LncRNA-HAGLR motivates triple negative breast cancer progression by regulation of WNT2 via sponging miR-335-3p. Jin L, Luo C, Wu X, Li M, Wu S, Feng Y. Aging (Albany NY); 2021 Aug 10; 13(15):19306-19316. PubMed ID: 34375306 [Abstract] [Full Text] [Related]
7. miR-331-3p Suppresses Cell Proliferation in TNBC Cells by Downregulating NRP2. Zhao M, Zhang M, Tao Z, Cao J, Wang L, Hu X. Technol Cancer Res Treat; 2020 Aug 10; 19():1533033820905824. PubMed ID: 32174262 [Abstract] [Full Text] [Related]
8. Long noncoding RNA LINC00885 upregulates NCK1 to promote cell viability and migration of triple-negative breast cancer cells through sponging miR-654-3p. He P, Liu Z, Qi J, Shan J, Sheng J. Cancer Biomark; 2024 Aug 10; 39(1):63-78. PubMed ID: 37694355 [Abstract] [Full Text] [Related]
10. Circ_0062558 promotes growth, migration, and glutamine metabolism in triple-negative breast cancer by targeting the miR-876-3p/SLC1A5 axis. Yuan M, Zhang J, He Y, Yi G, Rong L, Zheng L, Zhan T, Zhou C. Arch Gynecol Obstet; 2022 Nov 10; 306(5):1643-1655. PubMed ID: 35284960 [Abstract] [Full Text] [Related]
11. HIF-1α/Malat1/miR-141 Axis Activates Autophagy to Increase Proliferation, Migration, and Invasion in Triple-negative Breast Cancer. Xu F, Hu Y, Gao J, Wang J, Xie Y, Sun F, Wang L, Miyamoto A, Xia O, Zhang C. Curr Cancer Drug Targets; 2023 Nov 10; 23(5):363-378. PubMed ID: 36579395 [Abstract] [Full Text] [Related]
12. lncRNA GHET1 Promotes the Progression of Triple-Negative Breast Cancer via Regulation of miR-377-3p/GRSF1 Signaling Axis. Wang Y, Li C. Comput Math Methods Med; 2022 Nov 10; 2022():8366569. PubMed ID: 35509860 [Abstract] [Full Text] [Related]
13. Long noncoding RNA GAS5 suppresses triple negative breast cancer progression through inhibition of proliferation and invasion by competitively binding miR-196a-5p. Li S, Zhou J, Wang Z, Wang P, Gao X, Wang Y. Biomed Pharmacother; 2018 Aug 10; 104():451-457. PubMed ID: 29793177 [Abstract] [Full Text] [Related]
14. MiR-508-3p inhibits cell invasion and epithelial-mesenchymal transition by targeting ZEB1 in triple-negative breast cancer. Guo SJ, Zeng HX, Huang P, Wang S, Xie CH, Li SJ. Eur Rev Med Pharmacol Sci; 2018 Oct 10; 22(19):6379-6385. PubMed ID: 30338806 [Abstract] [Full Text] [Related]
15. CircWHSC1 regulates malignancy and glycolysis by the miR-212-5p/AKT3 pathway in triple-negative breast cancer. Ding L, Xie Z. Exp Mol Pathol; 2021 Dec 10; 123():104704. PubMed ID: 34624276 [Abstract] [Full Text] [Related]
16. miR-518a-3p Suppresses Triple-Negative Breast Cancer Invasion and Migration Through Regulation of TMEM2. Gan L, Yang H, Xiong Z, Yang Z, Wang T, Lyu G. Technol Cancer Res Treat; 2020 Dec 10; 19():1533033820977523. PubMed ID: 33251982 [Abstract] [Full Text] [Related]
17. LncRNA WEE2-AS1 promotes proliferation and inhibits apoptosis in triple negative breast cancer cells via regulating miR-32-5p/TOB1 axis. Wang R, Huang Z, Qian C, Wang M, Zheng Y, Jiang R, Yu C. Biochem Biophys Res Commun; 2020 Jun 11; 526(4):1005-1012. PubMed ID: 32307083 [Abstract] [Full Text] [Related]
18. MiR-92b inhibited cells EMT by targeting Gabra3 and predicted prognosis of triple negative breast cancer patients. Li YY, Zheng XH, Deng AP, Wang Y, Liu J, Zhou Q, Cheng GY, Jiang Q. Eur Rev Med Pharmacol Sci; 2019 Dec 11; 23(23):10433-10442. PubMed ID: 31841197 [Abstract] [Full Text] [Related]
19. Circular RNA dehydrodolichyl diphosphate synthase facilitated triple-negative breast cancer progression via miR-362-3p/DDX5 axis. Cui S, Zhang Y, Xing L, Li R, Piao Y, Liu H. Environ Toxicol; 2022 Jun 11; 37(6):1483-1494. PubMed ID: 35343646 [Abstract] [Full Text] [Related]
20. CCAT1 promotes triple-negative breast cancer progression by suppressing miR-218/ZFX signaling. Han C, Li X, Fan Q, Liu G, Yin J. Aging (Albany NY); 2019 Jul 16; 11(14):4858-4875. PubMed ID: 31310241 [Abstract] [Full Text] [Related] Page: [Next] [New Search]